| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/24/2004 | US6780967 Metal chelate-labelled peptides |
| 08/24/2004 | US6780846 Membrane translocating peptide drug delivery system |
| 08/24/2004 | US6780845 Compounds and methods for cancer therapy |
| 08/24/2004 | US6780843 Sequence and method for genetic engineering of proteins with cell membrane translocating activity |
| 08/24/2004 | US6780625 Glycogen synthase kinase-3 inhibitors |
| 08/24/2004 | CA2173626C B1k chain of laminin and methods of use |
| 08/19/2004 | WO2004069861A1 Peptidic sulfonamides |
| 08/19/2004 | WO2004069858A2 Leukocyte stimulating peptides |
| 08/19/2004 | WO2004069857A2 “peptides, compositions and uses thereof” |
| 08/19/2004 | WO2004069165A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/19/2004 | WO2004068928A2 Bradykinin b2 receptor antagonist peptide from amphibian skin |
| 08/19/2004 | WO2004043994A3 A retro-inverso gonadotropin-releasing hormone peptide and vaccine composition |
| 08/19/2004 | WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | US20040162415 growth and activity promotion effects on osteoblasts |
| 08/19/2004 | US20040162242 Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof |
| 08/19/2004 | US20040162239 For therapy of diseases associated with aberrant vascularization |
| 08/19/2004 | US20040162234 Glycogen synthase kinase-3 inhibitors |
| 08/19/2004 | US20040161843 Administering a peptide fragments from proteins that function as T-cell epitopes of human cytomegalovirus(HCMV) in human are capable of directing human cytotoxic T lymphocytes (CTL) to recognize and lyse human cells to infection with HCMV |
| 08/19/2004 | US20040161795 Systems and methods for analysis of protein post-translational modification |
| 08/19/2004 | US20040161383 Diagnostic agents for pancreatic exocrine function |
| 08/19/2004 | CA2515127A1 Peptidic sulfonamides |
| 08/18/2004 | EP1447408A1 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and therapeutics produced therewith |
| 08/18/2004 | EP1446426A2 Peptide purification by means of metal ion affinity chromatography |
| 08/18/2004 | EP1315739B1 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 08/18/2004 | EP0775160B1 Cyclic hexapeptide somatostatin analogues |
| 08/18/2004 | CN1522306A New assays for preimplantation factor and preimplantation factor peptides |
| 08/18/2004 | CN1520838A Bitter gourd extract plant insulin ; novel use of bitter gourd saponin |
| 08/18/2004 | CN1520827A Amino acid loaded trityl alcohol resins, method of producing same and use thereof |
| 08/17/2004 | US6777535 Useful for treating conditions which arise or are exacerbated by angiogenesis |
| 08/17/2004 | US6777199 Rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 08/17/2004 | US6777195 Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants |
| 08/17/2004 | US6777176 Target system |
| 08/12/2004 | WO2004067021A1 Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges |
| 08/12/2004 | WO2004046166A3 Modified alpha-msh peptides and derivatives thereof |
| 08/12/2004 | WO2004043396A3 Modified carbamate-containing prodrugs and methods of synthesizing same |
| 08/12/2004 | WO2004031374A3 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 08/12/2004 | WO2004029073A3 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 08/12/2004 | WO2004003561A9 Peptide rod amphiphiles and self-assembly of same |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040158037 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and biologically active substances and therapeutics produced therewith |
| 08/12/2004 | US20040158034 Echinocandin process |
| 08/12/2004 | US20040157782 killing or inhibiting the multiplication of tumor cells or cancer cells or as an immunosuppresant |
| 08/12/2004 | US20040157768 Cyclosporins for the treatment of immune disorders |
| 08/12/2004 | US20040156839 blocking the interaction of IgG with FC gamma R and blocking the interaction of IgE with Fc epsilon RI or IgA with Fc alpha RI; treatment of: autoimmune disease such as lupus, autoimmune glomerulonephritis and immune thrombocytopenic purpura |
| 08/12/2004 | CA2453809A1 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins, and biologically active substances and therapeutics produced therewith |
| 08/11/2004 | EP1444253A2 Pna-conjugates for treating chronic myeloid leukemia (cml) |
| 08/11/2004 | EP1444251A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 08/11/2004 | EP1444204A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 08/11/2004 | EP1444194A1 N-methyl-homocystines, use thereof and method for the production thereof |
| 08/11/2004 | EP1443972A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 08/11/2004 | EP1443923A1 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 08/11/2004 | EP1443861A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 08/11/2004 | EP1443860A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 08/11/2004 | EP1351977B1 Antimicrobial pseudopeptides |
| 08/11/2004 | EP1282638A4 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 08/11/2004 | EP0910576B1 Fusogenic liposomes |
| 08/11/2004 | EP0867450B1 TFPI-related Peptides which inhibit growth of smooth muscle cells |
| 08/11/2004 | EP0804453A4 Method for detection and treatment of breast cancer |
| 08/11/2004 | EP0642666B2 Hepatitis c assay |
| 08/11/2004 | CN1161462C Deacylation of cyclic lipopetides |
| 08/11/2004 | CN1161379C Novel peptides derived from autoantigent for use in immunitherapy of autoimmune diseases |
| 08/11/2004 | CN1161374C Cyclopeptides of formulal |
| 08/11/2004 | CN1161372C Novel peptide having biological activity |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774216 Antibody for use in diagnosis and treatment of immunological, inflammatory and nervous system disorders |
| 08/10/2004 | US6774212 For therapy of viral infection or as an assay standard or reagent |
| 08/10/2004 | US6774211 Peptide antiangiogenic drugs |
| 08/10/2004 | US6774209 Synthetic, isolated polypeptides overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon; for imaging |
| 08/10/2004 | US6774117 MN gene and protein |
| 08/10/2004 | US6773908 From open reading frames; vaccines |
| 08/10/2004 | US6773707 Employing hybrid antigen complex |
| 08/10/2004 | CA2315266C Wound healing compositions |
| 08/10/2004 | CA2255661C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 08/10/2004 | CA2191872C Beta sheet forming peptides and gels made thereof |
| 08/10/2004 | CA2129101C Synthetic haemophilus influenzae conjugate vaccine |
| 08/05/2004 | WO2004065621A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | WO2004065557A2 PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF ssDNA VIRUSES |
| 08/05/2004 | WO2004065413A1 Novel substances k01-b0171 and process for producing the same |
| 08/05/2004 | WO2004064787A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064780A2 Peptide-based angiogenesis inhibitors and methods of use thereof |
| 08/05/2004 | WO2004064709A2 Thrombolytic agent |
| 08/05/2004 | WO2004064595A2 Multivalent constructs for therapeutic and diagnostic applications |
| 08/05/2004 | WO2004050687A3 Cyclosporins for the treatment of autoimmune diseases |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | WO2003044045A3 Peptides promoting cell adherence, growth and secretion |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | US20040152869 Comprises amino acid sequences which serve as substrates for a disintegrin and metalloprotease (ADAM) for use in identification of modulator for treatment of asthma |
| 08/05/2004 | US20040152769 Anticancer, antitumor agents; viricides; antiarthritic agents |
| 08/05/2004 | US20040152639 Peptide hormone analogs of GnRH designed to be useful in male and female fertility regulation, post-coital contraception and as a menses-inducing agent, for managing ovarian cyst, polycystic ovarian disease, in vitro fertilization |
| 08/05/2004 | US20040152638 Protegrins |
| 08/05/2004 | US20040152193 Comprises peptide which binds to human leukocyte antigen on surface of cells and can be used as beacon for tissue targeted therapy in tumor cells |
| 08/05/2004 | US20040152134 Eating disorders; sexual disorders; erectile dysfunction |
| 08/05/2004 | US20040152098 Cellular signal-responsive gene transcriptional regulation system |
| 08/05/2004 | US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/05/2004 | DE19737245B4 Faseriger Mikrotubus aus einer Oligoglycinverbindung und Verfahren zur Herstellung des faserigen Mikrotubus Fibrous Mikrotubus from a Oligoglycinverbindung and method for producing the fibrous Mikrotubus |
| 08/05/2004 | CA2513320A1 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | CA2513044A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | CA2512780A1 Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
| 08/04/2004 | EP1442296A2 Biological assay detection method |